Medication info
Telmirepine Tablets 80/5 mg

Telmirepine Tablets 80/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Hwa-il Pharmaceutical Co., Ltd.
Appearance
Biconvex oval double tablets in white and light blue
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201903294 · Approved 2019.05.21 · Insurance code 684501570

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with an individual component as follows, switching directly to this medicine may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients who require careful administration’.) In older adults aged 75 years or over, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Hwa-il Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

Telmisartan and amlodipine are each medications used to lower blood pressure. This medication is used for patients with essential hypertension whose blood pressure control is insufficient with monotherapy of either of these two drugs. In other words, when basic blood pressure management is difficult, other treatment options will be considered.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with an individual component as follows, switching directly to this medicine may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients who require careful administration’.) In older adults aged 75 years or over, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is planned or confirmed, the administration of this medication should be discontinued as soon as possible. This medication should not be administered to women who are allergic to certain components, pregnant or nursing women, or patients with severely impaired liver or heart function. Additionally, it should not be used by patients with cholestatic disease, severe hypotension, or unstable conditions after heart failure or acute myocardial infarction. Caution should be exercised when administering this medication to patients with impaired liver or kidney function, and elderly patients should also use it with care. It may pose risks for patients with excessively low blood pressure or heart function issues, so they should follow their doctor's instructions. Dizziness or edema may occur during the administration of this medication, and if symptoms are severe, medical consultation should be sought immediately. Furthermore, hyperkalemia may occur, so it is important to periodically check potassium levels through blood tests. There may also be interactions with other medications, so all medications being taken should be disclosed to the doctor or pharmacist. Special caution is needed when taken in conjunction with medications like lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. This medication may cause drowsiness or dizziness, so caution is advised when driving or operating machinery. In the event of overdose, hypotension or heart-related issues may arise, necessitating immediate medical attention. This medication is not recommended for children, and it should be stored out of reach of children.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 102 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • decreased sensation
  • dysgeusia
  • tremors
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • gastrointestinal bleeding
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • elevated blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that blocks light, preferably at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the medication’s efficacy and prevent degradation.

Appearance and packaging

Appearance

Biconvex oval double tablets in white and light blue

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.